Magnetic tool looks viable for retrieving stone fragments

Rendering stone fragments paramagnetic by exposure to iron oxide-based microparticles shows promise as a novel approach for reducing the number of small retained fragments after ureteroscopic lithotripsy, say researchers who are developing the technology.

Related Videos

Related Content

Advertisement

January 23rd 2025

Standard pathology reports may be difficult to understand for patients with prostate cancer

Hannah Clarke

Overall, 39% of those who received a university-formatted report and 56% of those who received a VA-formatted report were able to identify that they had prostate cancer.

January 14th 2025

Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Wayne Kuang, MD Steven Maislos, MD

Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.

January 22nd 2025

Genomic tests may offer valuable prognostic insights, but clinical utility remains unclear

Hannah Clarke

"[The] full integration [of genomic classifier tests] into clinical practice requires additional research to better understand their cost-effectiveness, clinical utility, and impact on diverse populations," says Amir Alishahi Tabriz, MD, PhD, MPH.

November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

January 21st 2025

ICG-guided technique improves surgical time, accuracy of PLND

Hannah Clarke

The accuracy of PLND was 93.41% in the ICG injection arm compared with 75.91% in the control arm.

January 21st 2025

Incorporating mpMRI in bladder cancer staging may improve time to treatment

Hannah Clarke

The median time to correct treatment was 98 days with initial TURBT vs 53 days with initial mpMRI.

Related Content

Advertisement

January 23rd 2025

Standard pathology reports may be difficult to understand for patients with prostate cancer

Hannah Clarke

Overall, 39% of those who received a university-formatted report and 56% of those who received a VA-formatted report were able to identify that they had prostate cancer.

January 14th 2025

Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Wayne Kuang, MD Steven Maislos, MD

Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.

January 22nd 2025

Genomic tests may offer valuable prognostic insights, but clinical utility remains unclear

Hannah Clarke

"[The] full integration [of genomic classifier tests] into clinical practice requires additional research to better understand their cost-effectiveness, clinical utility, and impact on diverse populations," says Amir Alishahi Tabriz, MD, PhD, MPH.

November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

January 21st 2025

ICG-guided technique improves surgical time, accuracy of PLND

Hannah Clarke

The accuracy of PLND was 93.41% in the ICG injection arm compared with 75.91% in the control arm.

January 21st 2025

Incorporating mpMRI in bladder cancer staging may improve time to treatment

Hannah Clarke

The median time to correct treatment was 98 days with initial TURBT vs 53 days with initial mpMRI.